Covering Cutting-Edge Scientific and Business Trends in Drug Delivery
Pharma, biotech and drug delivery industries will gather at the 14th annual PODD event to assess delivery needs, information on deals and and latest trends in innovative drug delivery technologies. This includes small molecules, biologics, combination products, connected devices, cell and gene delivery and more.
PODD provides partnering opportunities through organized networking for new, emerging and established collaborations.
2024 Topics Include
- Ex-Liver Delivery of RNA/DNA
- Payer Perspectives on Drug Delivery
- Realities of Developing Self Administration of Subcutaneous Therapeutics
- AI Approaches to Deliver Cell & Gene Therapy
- Improving Bioavailability and Stability Through Excipient Innovation
- Balancing Between Concentration and Volume for Patient-Centric Biologics
- Designing and Developing Drug Delivery for LMICs
- New Approaches to Achieve BBB Permeability without Increasing Toxicity
- Advances in Pulmonary Delivery of Biologics
- Translating Digital Health from the Clinic to Commercialization
- Vaccine Delivery Innovations
- Achieving Oral Delivery of Peptides
- Developing Closed Loop Systems and Companion Diagnostics
- Sustained Release Innovations to Reduce Patient Burden
- Focused Ultrasound Delivery for CNS
- Biomaterial Implants to Reduce Patient Burden
2024 Keynotes
Gene Delivery Keynote
Dr Laura Sepp-Lorenzino
Intellia Therapeutics
Annual Keynote
Dr Robert Langer
MIT
Keynote
Dr Richard Tillyer
Johnson & Johnson
GLP-1 Zeitgeist
Dr Anand Subramony
Eli Lilly
2024 Featured Speakers
Co-Chair
Dr Sherri Biondi
AstraZeneca
Co-Chair
Dr Clare Beddoes
Cambridge Design Partnership
Co-Chair
Dr Aly Jackson
Genentech / Roche
Dr Advait Badkar
Pfizer
Dr Khaudeja Bano
Amgen
Dr Stephen Buckley
Novo Nordisk
Dr Ester Caffarel-Salvador
Chiesi USA
Dr Dany Doucet
GSK
Dr Josh Horvath
Genetech
Dr Elisa Konofagou
Colombia University
Dr Adam Procopio
Merck
Dr Samantha Sarett
Eli Lilly
2024 Drug Delivery Techology Track Options
- Injectable Formulations & Technologies
- Oral, Mucosal, Nasal & Other Non-Injectable Technologies
- Novel Devices: Self-Injectables, Wearables & Connected Devices
- Cell & Gene Delivery
- Excipient Innovation
- Novel Device Technologies
- Cell, Gene & Novel Biologics Delivery
- Self-Injection Devices, Syringes, Primary Container & Packaging Solutions
Additional Program Features
• Convenes 750+ Attendees from Pharma, Biotech, Drug Delivery, Academia, Investors and More
• Pharma Company Spotlights on Drug Delivery Needs and Partnering Philosophies
• Technology Presentations – 10 Tracks Covering a Wide Range of Drug Delivery Technologies
• Partnering Opportunities that include One-on-One Scheduled Meetings to Help Foster New Collaborations
The PODD Promise
1. Present a strategic-level program for pharma and biotech scientists and business development professionals, with a thorough overview on formulation needs, the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
2. Provide drug delivery and specialty pharmas with a platform to
present their technologies.
3. Offer ample networking time and services for one-on-one meetings to establish new business contacts and enhance existing ones.